ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Peptides
Volume 28, Issue 9, September 2007, Pages 1856-1870
Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (530 K)

Article Toolbox
  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.peptides.2007.04.004    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2007 Elsevier Inc. All rights reserved.

Microarray analyses of pituitary adenylate cyclase activating polypeptide (PACAP)-regulated gene targets in sympathetic neurons

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Karen M. Braasa, Kristin C. Schutza, Jeffrey P. Bondc, Margaret A. Vizzarda, b, Beatrice M. Girarda, b and Victor Maya, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Anatomy and Neurobiology, The University of Vermont College of Medicine, Burlington, VT 05405, United States

bDepartment of Neurology, The University of Vermont College of Medicine, Burlington, VT 05405, United States

cDepartment of Bioinformatics Core Facility, The University of Vermont College of Medicine, Burlington, VT 05405, United States


Received 1 February 2007; 
revised 29 March 2007; 
accepted 10 April 2007. 
Available online 19 April 2007.

Abstract

The high and preferential expression of the PAC1(short)HOP1 receptor in postganglionic sympathetic neurons facilitates microarray studies for mechanisms underlying PACAP-mediate neurotrophic signaling in a physiological context. Replicate primary sympathetic neuronal cultures were treated with 100 nM PACAP27 either acutely (9 h) or chronically (96 h) before RNA extraction and preparation for Affymetrix microarray analysis. Compared to untreated control cultures, acute PACAP treatment modulated significantly the expression of 147 transcripts of diverse functional groups, including peptides, growth factors/cytokines, transcriptional factors, receptors/signaling effectors and cell cycle regulators, that collectively appeared to facilitate neuronal plasticity, differentiation and/or regeneration processes. Some regulated transcripts, for example, were related to BDNF/TrkB, IL-6/Jak2/Socs2 and TGF/follistatin signaling; many transcripts affected bioactive peptide and polyamine biosynthesis. Although chronic PACAP treatments altered the expression of 109 sympathetic transcripts, only 43 transcripts were shared between the acute and chronic treatment data sets. The PACAP-mediated changes in transcript expression were corroborated independently by quantitative PCR measurement. The PACAP-regulated transcripts in sympathetic neurons did not bear strong resemblance to those in PACAP-treated pheochromocytoma cells. However, many PACAP-targeted sympathetic transcripts, especially those related to peptide plasticity and nerve regeneration processes, coincided significantly with genes altered after peripheral nerve injury. The ability for sympathetic PAC1(short)HOP1 receptors to engage multiple downstream signaling cascades appeared to be reflected in the number and diversity of genes targeted in a multifaceted strategy for comprehensive neurotrophic responses.

Keywords: PACAP; PAC1 receptor; Sympathetic; Superior cervical ganglion; Neurotrophic

Article Outline

1. Introduction
2. Method
2.1. Neuronal cell cultures and treatments
2.2. Microarray assay and analyses
2.3. Microarray statistics
2.4. Reverse transcription-polymerase chain reaction (PCR)
2.5. Real-time quantitative PCR and data analyses
3. Results
3.1. Acute sympathetic transcript responses to PAC1 receptor activation
3.2. Altered sympathetic transcript expression following chronic PACAP stimulation
3.3. Quantitative PCR assessment of PACAP gene targets
4. Discussion
Acknowledgements
References



Corresponding Author Contact InformationCorresponding author at: Departments of Anatomy & Neurobiology, and Pharmacology, University of Vermont College of Medicine, 149 Beaumont Avenue, Health Science Research Facility, Room 428, Burlington, VT 05405, United States. Tel.: +1 802 656 4579; fax: +1 802 656 8704.

Peptides
Volume 28, Issue 9, September 2007, Pages 1856-1870
Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.